Correlation Between Madrigal Pharmaceuticals and 89bio
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and 89bio Inc, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and 89bio.
Diversification Opportunities for Madrigal Pharmaceuticals and 89bio
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Madrigal and 89bio is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and 89bio go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and 89bio
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.22 times more return on investment than 89bio. However, Madrigal Pharmaceuticals is 1.22 times more volatile than 89bio Inc. It trades about 0.34 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.12 per unit of risk. If you would invest 21,700 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 12,818 from holding Madrigal Pharmaceuticals or generate 59.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. 89bio Inc
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| 89bio Inc |
Madrigal Pharmaceuticals and 89bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and 89bio
The main advantage of trading using opposite Madrigal Pharmaceuticals and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
| 89bio vs. Eliem Therapeutics | 89bio vs. HCW Biologics | 89bio vs. Scpharmaceuticals | 89bio vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |